Argenx Advances Efgartigimod Into China With Zai Lab Pact

Selects Option Of $75m In Stock For Upfront

 
• By Kevin Grogan
Shanghai
200,000 people in China live with myasthenia gravis. • Source: Shutterstock

More from Deals

More from Business